title: Novel insights into lithium's mechanism of action: neurotrophic and neuroprotective effects.
abstract: The monovalent cation lithium partially exerts its effects by activating neurotrophic and neuroprotective cellular cascades. Here, we discuss the effects of lithium on oxidative stress, programmed cell death (apoptosis), inflammation, glial dysfunction, neurotrophic factor functioning, excitotoxicity, and mitochondrial stability. In particular, we review evidence demonstrating the action of lithium on cyclic adenosine monophosphate (cAMP)-mediated signal transduction, cAMP response element binding activation, increased expression of brain-derived neurotrophic factor, the phosphatidylinositide cascade, protein kinase C inhibition, glycogen synthase kinase 3 inhibition, and B-cell lymphoma 2 expression. Notably, we also review data from clinical studies demonstrating neurotrophic effects of lithium. We expect that a better understanding of the clinically relevant pathophysiological targets of lithium will lead to improved treatments for those who suffer from mood as well as neurodegenerative disorders.
authors.affiliation: Hoffman-La Roche Inc., Pharma Development and Exploratory Neuroscience, Nutley, NJ, USA.
authors.forename: Jorge A
authors.initials: JA
authors.lastname: Quiroz
authors.forename: Rodrigo
authors.initials: R
authors.lastname: Machado-Vieira
authors.forename: Carlos A
authors.initials: CA
authors.lastname: Zarate
authors.forename: Husseini K
authors.initials: HK
authors.lastname: Manji
mesh_terms: D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology*; D006801:Humans; D018020:Lithium Compounds / Q000494:pharmacology*; D009414:Nerve Growth Factors / Q000378:metabolism*; D009474:Neurons / Q000187:drug effects* / Q000378:metabolism*; D018696:Neuroprotective Agents / Q000494:pharmacology*
chemical_list: D014150:Antipsychotic Agents; D018020:Lithium Compounds; D009414:Nerve Growth Factors; D018696:Neuroprotective Agents
references.citation: J Biol Chem. 1988 Oct 5;263(28):14559-65
references.pmid: 2844776
references.citation: Pharmacol Biochem Behav. 1998 Jan;59(1):191-200
references.pmid: 9443555
references.citation: Mol Psychiatry. 2002;7(8):845-50
references.pmid: 12232777
references.citation: Trends Neurosci. 1988 Mar;11(3):117-23
references.pmid: 2465609
references.citation: Neuropsychopharmacology. 1999 Oct;21(4):519-29
references.pmid: 10481836
references.citation: Neuropsychopharmacology. 2008 May;33(6):1229-38
references.pmid: 17687266
references.citation: Arch Biochem Biophys. 1974 Sep;164(1):194-201
references.pmid: 4372945
references.citation: Biol Psychiatry. 2004 Oct 1;56(7):467-75
references.pmid: 15450781
references.citation: Biochemistry. 1984 Jan 17;23(2):252-60
references.pmid: 6230103
references.citation: Trends Pharmacol Sci. 2003 Sep;24(9):441-3
references.pmid: 12967765
references.citation: J Neurochem. 2001 May;77(3):796-803
references.pmid: 11331408
references.citation: J Clin Psychiatry. 2009 Apr 21;70(5):699-705
references.pmid: 19389332
references.citation: J Neurosci. 2004 Jul 28;24(30):6791-8
references.pmid: 15282284
references.citation: J Biol Chem. 1980 Nov 25;255(22):10896-901
references.pmid: 6253491
references.citation: J Mol Neurosci. 2001 Apr-Jun;16(2-3):243-61; discussion 279-84
references.pmid: 11478380
references.citation: Eur J Neurosci. 2002 May;15(10):1681-91
references.pmid: 12059976
references.citation: Biol Psychiatry. 1999 Oct 1;46(7):929-40
references.pmid: 10509176
references.citation: Behav Pharmacol. 2006 Jun;17(4):311-8
references.pmid: 16914949
references.citation: J Neurochem. 1999 Feb;72(2):879-82
references.pmid: 9930766
references.citation: Psychopharmacol Bull. 2001 Spring;35(2):5-49
references.pmid: 12397885
references.citation: Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11824-8
references.pmid: 11553785
references.citation: Bipolar Disord. 2002 Apr;4(2):129-36
references.pmid: 12071510
references.citation: Biochim Biophys Acta. 1993 Jun 30;1177(3):253-69
references.pmid: 8391849
references.citation: Neuroreport. 1999 Dec 16;10(18):3887-90
references.pmid: 10716228
references.citation: Brain Res. 2004 Oct 22;1024(1-2):183-92
references.pmid: 15451381
references.citation: J Neurochem. 1995 Dec;65(6):2500-8
references.pmid: 7595544
references.citation: Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8455-9
references.pmid: 8710892
references.citation: Int J Neuropsychopharmacol. 2007 Feb;10(1):63-71
references.pmid: 16420717
references.citation: J Neurosci. 2003 Aug 13;23(19):7311-6
references.pmid: 12917364
references.citation: Mol Psychiatry. 2002;7 Suppl 1:S46-56
references.pmid: 11986995
references.citation: Int J Neuropsychopharmacol. 2007 Feb;10(1):7-19
references.pmid: 16672106
references.citation: Cell. 1989 Nov 3;59(3):411-9
references.pmid: 2553271
references.citation: J Neurochem. 1997 Dec;69(6):2336-44
references.pmid: 9375664
references.citation: Int J Neuropsychopharmacol. 2003 Sep;6(3):225-31
references.pmid: 12974988
references.citation: Int J Neuropsychopharmacol. 2007 Aug;10(4):491-6
references.pmid: 16923323
references.citation: Biochem Biophys Res Commun. 2001 Jan 26;280(3):720-5
references.pmid: 11162580
references.citation: Brain Res Mol Brain Res. 2005 Jun 13;137(1-2):193-201
references.pmid: 15950778
references.citation: Biol Psychiatry. 2004 Apr 15;55(8):781-4
references.pmid: 15050857
references.citation: Neurosci Lett. 1996 Dec 20;220(3):171-4
references.pmid: 8994220
references.citation: Neuropsychopharmacology. 2008 Jan;33(2):361-7
references.pmid: 17406649
references.citation: Biochem J. 1982 Sep 15;206(3):587-95
references.pmid: 7150264
references.citation: Bipolar Disord. 2009 Jun;11 Suppl 2:92-109
references.pmid: 19538689
references.citation: J Neurosci. 2005 May 4;25(18):4493-502
references.pmid: 15872096
references.citation: Annu Rev Pharmacol Toxicol. 2009;49:327-47
references.pmid: 18928402
references.citation: Neurochem Res. 1998 Jun;23(6):887-92
references.pmid: 9572678
references.citation: Psychopharmacology (Berl). 2007 Dec;195(3):357-67
references.pmid: 17705060
references.citation: Neuropharmacology. 2007 Sep;53(4):487-95
references.pmid: 17686496
references.citation: Curr Drug Targets. 2006 Nov;7(11):1421-34
references.pmid: 17100582
references.citation: Neuropharmacology. 2002 Dec;43(7):1173-9
references.pmid: 12504924
references.citation: J Neural Transm (Vienna). 2007;114(4):405-16
references.pmid: 16906355
references.citation: J Biol Chem. 1992 Aug 25;267(24):16878-82
references.pmid: 1324914
references.citation: Arch Gen Psychiatry. 2008 Mar;65(3):255-63
references.pmid: 18316672
references.citation: Neuropsychopharmacology. 2004 Jan;29(1):32-8
references.pmid: 12942141
references.citation: Behav Pharmacol. 2008 May;19(3):217-24
references.pmid: 18469539
references.citation: J Neurosci. 2008 Mar 5;28(10):2576-88
references.pmid: 18322101
references.citation: Mol Psychiatry. 1999 Jan;4(1):21-5
references.pmid: 10089004
references.citation: Psychopharmacology (Berl). 2001 Oct;158(1):100-6
references.pmid: 11685390
references.citation: Biochem Pharmacol. 1982 Mar 15;31(6):1025-31
references.pmid: 6211175
references.citation: Trends Neurosci. 1995 Feb;18(2):64-5
references.pmid: 7537411
references.citation: J Psychosom Res. 2002 Aug;53(2):687-97
references.pmid: 12169343
references.citation: Biol Psychiatry. 2002 Sep 1;52(5):404-12
references.pmid: 12242056
references.citation: Neuropsychopharmacology. 1996 Oct;15(4):370-81
references.pmid: 8887991
references.citation: FEBS Lett. 1997 Jul 14;411(2-3):183-8
references.pmid: 9271202
references.citation: J Neurochem. 1996 Aug;67(2):767-77
references.pmid: 8764606
references.citation: Clin Neurosci Res. 2002 Dec;2(3-4):193-212
references.pmid: 22707923
references.citation: Bipolar Disord. 2002 Apr;4(2):137-44
references.pmid: 12071511
references.citation: Biochem J. 2000 Oct 1;351(Pt 1):95-105
references.pmid: 10998351
references.citation: Arch Gen Psychiatry. 2000 Jan;57(1):95-7
references.pmid: 10632242
references.citation: Mol Psychiatry. 2009 Jan;14(1):51-9
references.pmid: 17925795
references.citation: Arch Gen Psychiatry. 2002 Jul;59(7):592-6
references.pmid: 12090811
references.citation: J Clin Psychiatry. 2004 Jan;65(1):10-21
references.pmid: 14744163
references.citation: J Psychiatr Res. 2008 Apr;42(5):416-21
references.pmid: 17512948
references.citation: J Biol Chem. 1999 Mar 5;274(10):6039-42
references.pmid: 10037682
references.citation: Autophagy. 2008 May;4(4):527-30
references.pmid: 18367867
references.citation: Neuropsychopharmacology. 2008 Oct;33(11):2551-65
references.pmid: 18235426
references.citation: Biol Psychiatry. 2000 Jul 1;48(1):1-8
references.pmid: 10913502
references.citation: Am J Psychiatry. 2008 Mar;165(3):313-20
references.pmid: 18245175
references.citation: Mol Psychiatry. 2002;7(6):604-8
references.pmid: 12140783
references.citation: Biochem J. 1988 Jan 1;249(1):143-8
references.pmid: 2829849
references.citation: Brain Res. 1992 Jan 20;570(1-2):333-40
references.pmid: 1617424
references.citation: Biochim Biophys Acta. 1978 Feb 10;522(2):434-42
references.pmid: 623770
references.citation: J Biol Chem. 2001 Oct 12;276(41):37794-801
references.pmid: 11500487
references.citation: Curr Opin Pharmacol. 2008 Feb;8(1):14-9
references.pmid: 18061540
references.citation: Anal Biochem. 1999 Jul 15;272(1):1-7
references.pmid: 10405286
references.citation: J Neurochem. 1993 Dec;61(6):2303-10
references.pmid: 8245981
references.citation: Bipolar Disord. 2007 Sep;9(6):561-70
references.pmid: 17845270
references.citation: Neurosci Lett. 2002 Aug 30;329(2):243-5
references.pmid: 12165422
references.citation: Basic Clin Pharmacol Toxicol. 2007 May;100(5):356-9
references.pmid: 17448124
references.citation: Int J Neuropsychopharmacol. 2001 Mar;4(1):47-64
references.pmid: 11343630
references.citation: Science. 1992 Oct 23;258(5082):607-14
references.pmid: 1411571
references.citation: Brain Res Bull. 2001 Jul 15;55(5):625-9
references.pmid: 11576759
references.citation: Biol Psychiatry. 2007 Jul 1;62(1):7-16
references.pmid: 17240360
references.citation: J Biol Chem. 2001 Aug 24;276(34):31674-83
references.pmid: 11418608
references.citation: Proc Natl Acad Sci U S A. 1995 May 23;92(11):5149-53
references.pmid: 7761465
references.citation: Invest Ophthalmol Vis Sci. 2003 Jan;44(1):347-54
references.pmid: 12506095
references.citation: Pharmacogenet Genomics. 2007 Aug;17(8):605-17
references.pmid: 17622937
references.citation: J Neurochem. 2002 Jul;82(1):137-45
references.pmid: 12091474
references.citation: Bipolar Disord. 2008 Jun;10(4):453-9
references.pmid: 18452441
references.citation: J Biol Chem. 2000 Mar 17;275(11):7583-90
references.pmid: 10713065
references.citation: Mol Genet Metab. 2004 May;82(1):87-92
references.pmid: 15110328
references.citation: Biol Psychiatry. 2004 Mar 15;55(6):570-7
references.pmid: 15013825
references.citation: Neuropsychopharmacology. 2007 Oct;32(10):2173-83
references.pmid: 17299510
references.citation: Int J Neuropsychopharmacol. 2004 Dec;7(4):387-90
references.pmid: 15315719
references.citation: Nature. 1997 Apr 24;386(6627):824-7
references.pmid: 9126739
references.citation: Pharmacopsychiatry. 2005 Jul;38(4):166-70
references.pmid: 16025419